IP Library Granted Patent US 10,653,720
Granted Patent B2
US 10,653,720 · App. 15/817,574 · Granted May 19, 2020

Prevention of protein glycation using lysine/zinc supplements

Inventor: John Burd (San Diego, CA)
Assignee: Lysulin, Inc.
A61K33/30A23L33/16A23L33/175A23L33/30A61B5/14532A61B5/4839A61K9/0053A61K31/198G01N33/66A23V2002/00G01N2800/52G08B21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,720
App. No.
15/817,574
Granted
May 19, 2020
Kind
B2
Abstract

A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.

Claims (11)

1. A method of monitoring blood sugar control, the method comprising:

administering a supplement consisting of lysine and zinc to a user;

monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and

determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.

2. The method of claim 1 , wherein a lysine portion of the supplement comprises D-lysine.

3. The method of claim 1 , wherein a lysine portion of the supplement comprises L-lysine.

4. The method of claim 1 , wherein monitoring the concentration of glucose comprises analyzing blood samples.

5. The method of claim 1 , wherein monitoring the concentration of glucose comprises analyzing urine samples.

6. The method of claim 1 , further comprising providing a notification on an automatic reader regarding a precise dosage of supplement to be administered.

7. The method of claim 6 , wherein the notification comprises a pop-up, a vibration, or a noise.

8. The method of claim 1 , wherein determining a change in dose comprises using a visual test to determine an amount of supplements to be administered, wherein the visual test comprises exposing the bio-sample to a reagent that causes a visible indication of a concentration range of glycated lysine within the bio-sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2019
From: BURD, JOHN
To: LYSULIN, INC.
Reel/Frame 049205/0005 →
Continuity (2)
Provisional Application 62581573 · Nov 3, 2017
Related Publication 20190134083A1 · May 9, 2019